The aim of this study was to evaluate hematuria-free survival as well as acute and late toxicity after hypofractionated palliative radiotherapy for bladder cancer.status: publishe
One third of patients with bladder cancer present with muscle invasive bladder cancer (MIBC) which h...
Purpose and objectives We report on the clinical outcomes of a phase 2 study assessing image guided ...
Objective: A previous paper reported favorable results of intra-arterial chemotherapy in combination...
PURPOSE: To compare the efficacy and toxicity of two hypofractionated radiotherapy schedules for the...
Objective: Comparative evaluation of the efficiency of palliative courses of external beam radiation...
Aim To evaluate acute toxicity and symptoms palliation of a weekly hypofractionated 3DCRT schedu...
Purpose: To investigate the early and late toxicity of a hypofractionated radiotherapy (RT) schedule...
The management of metastatic bladder cancer is palliative. Best outcomes are achieved in those who a...
BackgroundAlthough radical cystectomy is a standard treatment in muscle-invasive bladder cancer, bla...
Bladder cancer is the second most common malignancy of the genitourinary tract. The efficacy of RT i...
INTRODUCTION: Hematuria can be a distressing and debilitating complication of urothelial carcinoma (...
Purpose: To report long-term results of a bladder preservation strategy for muscle-invasive bladder ...
The role of radiotherapy (RT) in the treatment of urinary bladder cancer has undergone several modif...
Aim: To evaluate acute toxicity and symptoms palliation of a weekly hypofractionated 3DCRT schedule ...
PURPOSE: The aim of this study was to evaluate the outcomes of loco-regional hyperthermia (HT) with ...
One third of patients with bladder cancer present with muscle invasive bladder cancer (MIBC) which h...
Purpose and objectives We report on the clinical outcomes of a phase 2 study assessing image guided ...
Objective: A previous paper reported favorable results of intra-arterial chemotherapy in combination...
PURPOSE: To compare the efficacy and toxicity of two hypofractionated radiotherapy schedules for the...
Objective: Comparative evaluation of the efficiency of palliative courses of external beam radiation...
Aim To evaluate acute toxicity and symptoms palliation of a weekly hypofractionated 3DCRT schedu...
Purpose: To investigate the early and late toxicity of a hypofractionated radiotherapy (RT) schedule...
The management of metastatic bladder cancer is palliative. Best outcomes are achieved in those who a...
BackgroundAlthough radical cystectomy is a standard treatment in muscle-invasive bladder cancer, bla...
Bladder cancer is the second most common malignancy of the genitourinary tract. The efficacy of RT i...
INTRODUCTION: Hematuria can be a distressing and debilitating complication of urothelial carcinoma (...
Purpose: To report long-term results of a bladder preservation strategy for muscle-invasive bladder ...
The role of radiotherapy (RT) in the treatment of urinary bladder cancer has undergone several modif...
Aim: To evaluate acute toxicity and symptoms palliation of a weekly hypofractionated 3DCRT schedule ...
PURPOSE: The aim of this study was to evaluate the outcomes of loco-regional hyperthermia (HT) with ...
One third of patients with bladder cancer present with muscle invasive bladder cancer (MIBC) which h...
Purpose and objectives We report on the clinical outcomes of a phase 2 study assessing image guided ...
Objective: A previous paper reported favorable results of intra-arterial chemotherapy in combination...
DOI
Add to ORKG